首页> 外文期刊>ACS medicinal chemistry letters >Structure and Property Based Design of Pyrazolo[1,5-a]pyrimidine Inhibitors of CK2 Kinase with Activity in Vivo
【24h】

Structure and Property Based Design of Pyrazolo[1,5-a]pyrimidine Inhibitors of CK2 Kinase with Activity in Vivo

机译:具有体内活性的吡咯并[1,5-a]嘧啶抑制剂的结构和性质设计

获取原文
获取原文并翻译 | 示例
       

摘要

In this letter, we describe the design, synthesis, and structure?activity relationship of 5-anilinopyrazolo[1,5-a]pyrimidine inhibitors of CK2 kinase. Property-based optimization of early leads using the 7-oxetan-3-yl amino group led to a series of matched molecular pairs with lower lipophilicity, decreased affinity for human plasma proteins, and reduced binding to the hERG ion channel. Agents in this study were shown to modulate pAKTS129, a direct substrate of CK2, in vitro and in vivo, and exhibited tumor growth inhibition when administered orally in a murine DLD-1 xenograft.
机译:在这封信中,我们描述了CK2激酶的5-苯胺吡唑并[1,5-a]嘧啶抑制剂的设计,合成和结构活性关系。使用7-氧杂环丁-3-基氨基基团基于特性的早期潜在客户优化,导致一系列匹配的分子对具有较低的亲脂性,对人血浆蛋白的亲和力下降以及与hERG离子通道的结合减少。这项研究的药物在体外和体内显示出可调节pAKTS129(CK2的直接底物),并且在鼠DLD-1异种移植物中口服给药时具有肿瘤生长抑制作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号